Eka Funding
Book a demo
India Eliminates Trachoma: A Public Health Triumph
In a landmark achievement, India has been declared free of trachoma as a public health problem. This infectious eye disease, a leading cause of blindness, has been successfully eliminated through concerted efforts by the Indian government, healthcare workers and international organizations.
on
#
nobelprize
#
researchinhealth
MicroRNA Researchers Win 2024 Nobel Prize in Medicine
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA and its essential role in post-transcriptional gene regulation.
Eka Care
on
October 7, 2024
#
cancer
#
cervicalcancer
#
Vaccination
#
hpv
WHO Approves Single-Dose HPV Vaccine, Cecolin®
The World Health Organization (WHO) has approved the use of Cecolin®, a single-dose, as the fourth prequalified human papillomavirus (HPV) vaccine.The single-dose schedule has proven highly effective, with coverage among girls aged 9-14 increasing from 20% in 2022 to 27% in 2023. WHO estimates that this approach led to at least 6 million more girls receiving the HPV vaccine in 2023.
Eka Care
on
October 7, 2024
#
cancer
#
breast cancer
Breast Cancer Increasing Among Younger Women, Particularly Asian Americans
The American Cancer Society (ACS) published a report revealing mixed news regarding breast cancer trends in the U.S., while breast cancer deaths have decreased by 44% since the late 1980s, new diagnoses continue to rise year after year. This rise is greater among younger women, with rates increasing by 1.4% each year since 2021.
Eka Care
on
October 7, 2024
#
cancer
#
cancerresearch
#
genomics
India Launches First Comprehensive Cancer Genomics Database
The Indian Cancer Genome Atlas (ICGA) has launched India's first cancer multi-omics data portal, a critical milestone in the goal to transform cancer care in the nation through personalised medicine. Jointly supported by public and private funders in India, the ICGA aims to update the previous dependence on western datasets for cancer research in India.
Eka Care
on
October 7, 2024
Previous
Next
Featured
FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases
Participate in India’s healthcare revolution
Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)
Create ABHA ID
Popular topics
#
newfeature
#
Partnership
#
funding